» Articles » PMID: 1825481

Two Differential Pathways from Double-negative to Double-positive Thymocytes

Overview
Journal Immunology
Date 1991 Jan 1
PMID 1825481
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Murine thymocytes are divided into four major populations on the basis of expression of CD4 and CD8 antigens. The bulk of evidence favours the view that CD4-CD8- cells can develop into CD4-CD8+ and CD4+CD8- cells via the CD4+CD8+ stage in the thymus. However, CD4-CD8+ and CD4+CD8- thymocyte subsets contain not only CD3+ mature cells but also CD3- immature cells, which seem to be intermediate cells between CD4-CD8- and CD4+CD8+ cells. Here we demonstrate mouse strain differences in the proportion of immature single-positive thymocyte subsets in thymus at the steady or developing state. In C3H mice, immature CD4+CD8- is dominant in proportion over CD4-CD8+ in foetal thymus and in donor-derived thymocytes at an early stage of bone marrow transplantation. On the other hand, immature CD4-CD8+ is dominant over CD4+CD8- during T-cell development in the case of B10.BR mice. An intermediate pattern was shown in the case of F1 mice. Both of these immature single-positive subsets gave rise to double-positive cells after 24 hr culture. These results suggest that there exist two distinct differential pathways; one is from CD4-CD8- cells to CD4+CD8+ cells via CD4-CD8+ cells, and another is via CD4+CD8- cells, and that an application of the 'CD8 pathway' or 'CD4 pathway' seems to be genetically destined by BM-derived cells but not by thymic stromal cells.

Citing Articles

Characterization of fetal microchimeric immune cells in mouse maternal hearts during physiologic and pathologic pregnancies.

Lintao R, Kumar Kammala A, Radnaa E, Bettayeb M, Vincent K, Patrikeev I Front Cell Dev Biol. 2023; 11:1256945.

PMID: 37808080 PMC: 10556483. DOI: 10.3389/fcell.2023.1256945.


Modeling the development of the post-natal mouse thymus in the absence of bone marrow progenitors.

Zaharie D, Moleriu R, Mic F Sci Rep. 2016; 6:36159.

PMID: 27824070 PMC: 5099910. DOI: 10.1038/srep36159.


Mcph1/Brit1 deficiency promotes genomic instability and tumor formation in a mouse model.

Liang Y, Gao H, Lin S, Goss J, Du C, Li K Oncogene. 2014; 34(33):4368-78.

PMID: 25362854 PMC: 4417661. DOI: 10.1038/onc.2014.367.


Differentiation of CD3-4-8- human fetal thymocytes in vivo: characterization of a CD3-4+8- intermediate.

Kraft D, Weissman I, Waller E J Exp Med. 1993; 178(1):265-77.

PMID: 8315382 PMC: 2191096. DOI: 10.1084/jem.178.1.265.


Selective inhibition of immature CD4-CD8+ thymocyte proliferation, but not differentiation, by the thymus atrophy-inducing compound di-n-butyltin dichloride.

Pieters R, Bol M, Ariens T, Punt P, Seinen W, Bloksma N Immunology. 1994; 81(2):261-7.

PMID: 8157274 PMC: 1422326.


References
1.
Hugo P, Waanders G, Scollay R, Shortman K, Boyd R . Ontogeny of a novel CD4+CD8-CD3- thymocyte subpopulation: a comparison with CD4- CD8+ CD3- thymocytes. Int Immunol. 1990; 2(3):209-18. DOI: 10.1093/intimm/2.3.209. View

2.
Wysocki L, Sato V . "Panning" for lymphocytes: a method for cell selection. Proc Natl Acad Sci U S A. 1978; 75(6):2844-8. PMC: 392661. DOI: 10.1073/pnas.75.6.2844. View

3.
Hirokawa K, Sado T, Kubo S, Kamisaku H, Hitomi K, Utsuyama M . Intrathymic T cell differentiation in radiation bone marrow chimeras and its role in T cell emigration to the spleen. An immunohistochemical study. J Immunol. 1985; 134(6):3615-24. View

4.
MacDonald H, Hengartner H, Pedrazzini T . Intrathymic deletion of self-reactive cells prevented by neonatal anti-CD4 antibody treatment. Nature. 1988; 335(6186):174-6. DOI: 10.1038/335174a0. View

5.
Wilson A, Day L, Scollay R, Shortman K . Subpopulations of mature murine thymocytes: properties of CD4-CD8+ and CD4+CD8- thymocytes lacking the heat-stable antigen. Cell Immunol. 1988; 117(2):312-26. DOI: 10.1016/0008-8749(88)90121-9. View